Andrew M Brunner
13PUBLICATIONS
81CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.Jooho Chung, Mounica Vallurupalli, Sarah Noel
|Jan 04, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.Yannis K Valtis, Yael Flamand, Shai Shimony
|Nov 23, 2023
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.Andrew M Brunner, Jordi Esteve, Kimmo Porkka
|Apr 04, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.Amir T Fathi, Haesook T Kim, Robert J Soiffer
|Dec 14, 2022
Management of patients with lower-risk myelodysplastic syndromes.Andrew M Brunner, Heather A Leitch, Arjan A van de Loosdrecht
|Feb 10, 2022
Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly "promising"?Andrew M Brunner, Geoffrey Fell, David P Steensma
Pageof 3
Frequent Collaborators
2 joint publications
Daniel J DeAngelo
2 joint publications
David P Steensma
2 joint publications
Areej El-Jawahri
2 joint publications
Guillermo Garcia-Manero
1 joint publications
Robert T Manguso
1 joint publications
Rory M Shallis
1 joint publications
Pau Montesinos
1 joint publications
Raphaël Itzykson
1 joint publications
Nikolai A Podoltsev
1 joint publications
Jan Philipp Bewersdorf
